Results 1 to 10 of about 34,778 (264)

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries [PDF]

Frontiers in Pharmacology, 2023
Introduction: Advanced Therapy Medicinal Products are a type of therapies that, in some cases, hold great potential for patients without an effective current therapeutic approach but they also present multiple challenges to payers.
Juan Carlos Rejon-Parrilla, Jaime Espin, Jaime Espin, Jaime Espin, Jaime Espin, Sarah Garner, Stanislav Kniazkov, David Epstein   +7 more
doaj   +5 more sources

Key factors associated with China’s basic medical insurance fund revenue-expenditure balance: a grey relational analysis [PDF]

Cost Effectiveness and Resource Allocation
Introduction The financial equilibrium of China’s Basic Medical Insurance Fund (BMIF) is pivotal, as it directly influences the sustainability, equity, and stability of the healthcare security system.
Guangwen Gong, Wang Dan, Hu Wei, Li Xiping   +3 more
doaj   +2 more sources

Value-based Reimbursement as a Mechanism to Achieve Social and Financial Impact in the Healthcare System

Journal of Health Economics and Outcomes Research, 2023
# Background Value-based reimbursement strategies have been considered in the continuous search for establishing a sustainable healthcare system. For models that have been already implemented, success is demonstrated according to specific details of the ...
Ana Paula Beck de Silva Etges, Harry H. Liu, Porter Jones, Carisi A. Polanczyk   +3 more
doaj   +3 more sources

Challenges and solutions in determining urolithiasis caseloads using the digital infrastructure of a clinical data warehouse. [PDF]

PLoS ONE
BackgroundTo provide more evidence in urolithiasis research, we have established the German Nationwide Register for RECurrent URolithiasis (RECUR) using local clinical data warehouses (CDWH).
Martin Schönthaler, Noah Hempen, Maria Weymann, Maximilian Ferry von Bargen, Maximilian Glienke, Antonia Elsässer, Max Behrens, Harald Binder, Nadine Binder   +8 more
doaj   +2 more sources

Primary versus revision total shoulder arthroplasty: comparing relative value and reimbursement trends [PDF]

Clinics in Shoulder and Elbow, 2022
Background Total shoulder arthroplasty (TSA) has been demonstrated to be an effective treatment for multiple shoulder pathologies. The purpose of our study was to compare the relative value units (RVUs) per minute of surgical time for primary and ...
John Joseph Carney, Erik Gerlach, Mark Plantz, Peter Raymond Swiatek, Jeremy Marx, Matthew Saltzman, Guido Marra   +6 more
doaj   +1 more source

How Denmark, England, Estonia, France, Germany, and the USA Pay for Variable, Specialized and Low Volume Care: A Cross-country Comparison of In-patient Payment Systems [PDF]

International Journal of Health Policy and Management, 2022
Background  Diagnosis-related group (DRG)-based hospital payment can potentially be inadequately low (or high) for highly variable, highly specialized, and/or low volume care.
Wilm Quentin, Victor Stephani, Robert A. Berenson, Lone Bilde, Katja Grasic, Riina Sikkut, Mariama Touré, Alexander Geissler   +7 more
doaj   +1 more source

Effect of retirement on medical reimbursement expenses—evidence from China

Health Economics Review, 2023
Background Medical reimbursement in China is not for all diseases, and medical reimbursement expenses are not completely consistent with medical service demand, though the scope and proportion of medical reimbursement are gradually expanding.
Yuanyang Wu, Jiahui Pang, Hualei Yang
doaj   +1 more source

Incentives to transfer patients under alternative reimbursement mechanisms [PDF]

Journal of Public Economics, 1988
Alternative hospital reimbursement systems may influence the frequency and timing of patient transfers between hospitals as well as the patient's length of stay. This paper examines the characteristics of reimbursement systems that result in efficient and equitable transfers and efficient lengths of stay.
Randall P. Ellis, Christopher J. Ruhm
openaire   +1 more source

Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits

Cancer Medicine, 2020
Objectives Value‐based pricing of oncology drugs provides a best estimate for the price of a drug, as it relates to the benefits it provides for individual patients. To date, the impact of value‐based pricing to reference cost‐effectiveness thresholds (λ)
Ambica Parmar, Tina Jiao, Ronak Saluja, Kelvin K. W. Chan   +3 more
doaj   +1 more source

Analysis of changes in drug reimbursement based on the example of the limit groups containing beta-2 adrenergic drugs in Poland in the years 2012-2021 [PDF]

Farmacja Polska, 2022
Subject of the study The subject of the study is a price analysis of the limit groups of reimbursed beta-2 adrenergic drugs. Rationalisation of reimbursement expenditure, including generic substitution, is carried out in order to maximise health effects ...
Piotr Zbigniew Rykowski, Magdalena Władysiuk, Robert Plisko, Andrzej Stańczak   +3 more
doaj   +1 more source